[Basis for Insulin Lispro: physicochemical approach to fast-acting insulin analog].
Nakazawa
T
T
Scientific Affirs, Eli Lilly Japan.
Chance
R E
RE
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D007328:Insulin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D061268:Insulin Lispro; D017526:Receptor, IGF Type 1 / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism; D012869:Skin Absorption
D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin; D005947:Glucose